Most active investors · All time
Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
Browse by month
Details
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Epyr Undisclosed Selected for grant agreement preparationENOSIS Undisclosed Selected for grant agreement preparationDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Wavo €10M Equity financingActionable $10M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
HyLight €13M Funding roundRocapine $13M Series ADetails
Details
Details
New companies 1 · Follow-on 1
Stages: Pre-seed 1, Series A 1
Edonia €15M Series A financing package including non-dilutive and bank fundingEdonia €2M Pre-seedDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Vates €30M First external growth investmentWiremind €35M First external financingDetails
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Joe AI €2M UndisclosedLightspring €3.1M SeedDetails
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Inbolt €11M €11 million funding roundZeliq €7M Seed extensionDetails
Details
Details
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
HighLife €80M Financing roundQuobly €115M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Kheops €12M FundingBrightHeart €11M Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Hackuity $19M Series BQevlar AI $30M Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Kaiko $57M Series B-2 extensionLifeaz €13M Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Growth 1, Series A 1
Implicity €35M Growth equityOpsMill $14M Series ADetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
ArcSpace >€2M UndisclosedFineHeart €83M Series CDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Brenus Pharma €11M Series AStanding Ovation €30M Series BDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Brenus Pharma €11M Series AStanding Ovation €30M Series BDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Brenus Pharma €11M Series AEnodia Therapeutics €20.7M SeedDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Syntetica $30M Series AStanding Ovation €30M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.